Cargando…
Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
BACKGROUND: The HIV epidemic in the United States (US) disproportionately affects gay, bisexual, and other men who have sex with men (MSM). Pre-exposure prophylaxis (PrEP) using co-formulated tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) has demonstrated high efficacy in reducing HIV i...
Autores principales: | Montgomery, Madeline C., Oldenburg, Catherine E., Nunn, Amy S., Mena, Leandro, Anderson, Peter, Liegler, Teri, Mayer, Kenneth H., Patel, Rupa, Almonte, Alexi, Chan, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917105/ https://www.ncbi.nlm.nih.gov/pubmed/27333000 http://dx.doi.org/10.1371/journal.pone.0157742 |
Ejemplares similares
-
Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention
por: Patel, Rupa R., et al.
Publicado: (2017) -
Defining the HIV pre-exposure prophylaxis care continuum
por: Nunn, Amy S., et al.
Publicado: (2017) -
Long‐term retention in pre‐exposure prophylaxis care among men who have sex with men and transgender women in the United States
por: Chan, Philip A, et al.
Publicado: (2019) -
Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities
por: Chan, Philip A, et al.
Publicado: (2016) -
Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions
por: Siegler, Aaron J., et al.
Publicado: (2020)